News | November 21, 2011

Boston Scientific Begins Marketing Robotic, Remote Catheter System in Europe

November 21, 2011 — Boston Scientific has reached an exclusive agreement with Catheter Robotics Inc. (CRI) to market the CRI Amigo system, a remote-controlled catheter system and related accessories. The two companies will focus their efforts in select European countries.

The CRI Amigo system is compatible with certain Boston Scientific and other commercially available catheters. It lets physicians remotely maneuver diagnostic and ablation catheters designed to treat common cardiac arrhythmias during electrophysiology procedures. Boston Scientific plans to market the Amigo system in Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Portugal, Spain and Switzerland.

"To perform successful ablation procedures, electrophysiologists require precise control over catheter tip placement," said Jean Paul Albenque, M.D., Clinique Pasteur, Toulouse, France. "The Amigo Remote Catheter System, used in combination with the predictable steering and stability of Boston Scientific's leading RF ablation catheters, offers improved comfort and reduced radiation exposure without sacrificing performance."

The system is designed to integrate easily into existing cath labs for use in simple and complex procedures to diagnose and treat cardiac arrhythmias. It connects to the handle of specific electrophysiological catheters and lets the physician remotely operate the catheter with a controller. The system is intended to allow full operation of all catheter functions while reducing a physician's radiation exposure during the procedure.

The Amigo system is compatible with Boston Scientific's Blazer and Blazer Open-Irrigated radiofrequency (RF) ablation catheters and Chilli II fluid-cooled RF ablation catheter. The Blazer Open-Irrigated Catheter, launched in CE Mark countries in May 2011, is an advanced catheter that integrates Total Tip Cooling Design, which is intended to consistently cool the entire tip electrode during RF energy delivery.

Affecting more than 4.5 million Europeans, atrial fibrillation is an arrhythmia associated with a rapid rhythm in the upper chambers of the heart. Patients are most often treated with anti-arrhythmic drugs, which can often cause adverse side effects. Cardiac ablation with an RF ablation catheter is increasingly becoming an option for patients who cannot tolerate these medications.

In the United States, the Blazer Open-Irrigated Catheter is an investigational device, limited by applicable law to investigational use only and not available for sale.

For more information:,

Related Content

Corindus CorPath Used in World's First-in-Human Telerobotic Coronary Intervention
News | Robotic Systems | December 06, 2018
Corindus Vascular Robotics Inc. announced that its CorPath technology was used to conduct the first-in-human (FIH)...
Corindus Announces First Live Transmission of Remote Robotic Demonstration at TCT 2018
News | Robotic Systems | September 24, 2018
Corindus Vascular Robotics Inc. announced the first live transmission of a remote interventional procedure using the...
Corindus and Mayo Clinic Conducting Preclinical Telestenting Study of Remote PCI Capabilities
News | Robotic Systems | January 08, 2018
Corindus Vascular Robotics Inc. announced that it is working with Mayo Clinic in a preclinical study about use of...
Corindus and Houston Methodist DeBakey Heart & Vascular Center Launch Robotic Training Site
News | Robotic Systems | December 28, 2017
Corindus Vascular Robotics Inc. announced recently that Houston Methodist DeBakey Heart & Vascular Center has...
Robocath Receives $1.5 Million in Capital for Advancement of R-One Robotic System
News | Robotic Systems | December 06, 2017
December 6, 2017 — French company Robocath, which designs and develops...
Montreal Heart Institute Performs First Robotic Mitral Valve Surgery
News | Robotic Systems | September 22, 2017
The Montreal Heart Institute (MHI) announced the acquisition of the da Vinci Xi, a new-generation surgical robot, and...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems | September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Large Multicenter Study Shows High Success Rate for Robotic PCI Procedures, SCAI, Corindus CorPath 200
News | Robotic Systems | May 16, 2017
The largest real-world study of robotic percutaneous coronary intervention (PCI) demonstrated clinical and technical...
Robotic-Assisted PCI With CorPath GRX Broadcast Live at TCT Asia-Pacific Summit
News | Robotic Systems | May 01, 2017
Corindus Vascular Robotics Inc. announced that Fu Wai Hospital in China performed and broadcast live a percutaneous...
Clinical Study Validates Efficiencies of Stereotaxis Niobe ES System Over Niobe II System
News | Robotic Systems | April 24, 2017
A recent study conducted at Centre Hospitalier Universitaire (CHU) of Saint-Étienne, France validated the advantages of...
Overlay Init